Similarly, the CD133 stem cell marker, which has been reported to characterize CSCs and to be associated with a poor prognosis in different tumor types, and CD38 [40] are also repressed by RMST, thus confirming once again its involvement in the modulation of the stem phenotype [41]. This evidence concerns the gene CD38 and neoplasm.